Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „levels“
Suchtreffer
Begriffe & Kennungen
Efavirenz Teva · 4.5 · 8 Medicinal product by Effects on drug levels Recommendation concerning therapeutic areas Mean percent change
Eintrag öffnenEfavirenz Teva · 4.5 · 9 Medicinal product by Effects on drug levels Recommendation concerning therapeutic areas Mean percent change
Eintrag öffnenEfavirenz Teva · 4.8 · Amylase: In the clinical trial subset of 1,008 patients, asymptomatic increases in serum amylase levels greate
Eintrag öffnenEfavirenz Teva · 4.8 · Metabolic parameters Weight and levels of blood lipids and glucose may increase during antiretroviral therapy
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · 24 Similar results were found by other investigators, although the MPA plasma levels were more variable in the
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.5 · Medicinal product by therapeutic Effects on active substances levels Recommendation concerning areas Mean perc
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Krka · 4.8 · Metabolic parameters Weight and levels of blood lipids and glucose may increase during antiretroviral therapy
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 12 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 13 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 14 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 15 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 16 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 17 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 18 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 19 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 20 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 21 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 22 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 23 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnenEfavirenz/Emtricitabine/Tenofovir disoproxil Mylan · 4.5 · 24 Effects on medicinal product levels Recommendation concerning co- administration with Mean percent change i
Eintrag öffnen